je.st
news
Cancer-fighting CytomX lands $20 million Pfizer investment, makes key hires
2015-01-06 19:20:40| Biotech - Topix.net
CytomX's "probodies" make cancer-fighting drugs more effective with less collateral damage to healthy tissue, said CEO Sean McCarthy. CytomX Therapeutics Inc. grabbed $20 million led by Pfizer Inc.'s venture capital arm to help partner its sneaky cancer fighters with new types of drugs and build out its own portfolio.
Tags: key
makes
million
investment
Category:Biotechnology and Pharmaceuticals